STOCK TITAN

Insider in LH stock (NYSE: LH) plans 88-share Rule 144 sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder of the issuer filed a notice under Rule 144 for a planned sale of 88 shares of common stock through Fidelity Brokerage Services LLC. The filing lists an aggregate market value of 24,246.64 and shows 82,900,000 shares outstanding, with the sale expected around 02/09/2026 on the NYSE.

The 88 shares to be sold were acquired on 02/06/2026 via restricted stock vesting from the issuer as compensation, rather than a cash purchase. The signer represents that they are not aware of undisclosed material adverse information about the issuer’s current or prospective operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for LH disclose about share sales?

The filing discloses a planned sale of 88 shares of common stock under Rule 144. The shares are to be sold through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of 24,246.64 and 82,900,000 shares outstanding.

How were the 88 LH shares in this Form 144 acquired?

The 88 shares were acquired on 02/06/2026 through restricted stock vesting from the issuer. They were received as compensation rather than purchased for cash, and the same date is listed for acquisition and payment.

When are the LH shares in this Form 144 expected to be sold?

The approximate date of sale listed is 02/09/2026. The transaction is planned to occur on the NYSE through Fidelity Brokerage Services LLC, as part of a Rule 144 resale of restricted or control securities.

What market details are provided in the LH Form 144 filing?

The filing identifies the securities as common stock to be sold on the NYSE. It lists 88 shares with an aggregate market value of 24,246.64 and notes that 82,900,000 shares of the issuer’s stock are outstanding.

What representation does the seller make in the LH Form 144?

The seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed. This statement is part of the standard Rule 144 notice representation.
Labcorp Holdings Inc

NYSE:LH

LH Rankings

LH Latest News

LH Latest SEC Filings

LH Stock Data

22.72B
82.58M
0.34%
100.04%
3.31%
Diagnostics & Research
Services-medical Laboratories
Link
United States
BURLINGTON